MVK Agro Food Gets Mega Project Status; ₹275 Cr Expansion with Govt Incentives 11/04/2026 / Operations & Projects / Investment Expansion with Subsidy Benefits MVK Agro Food Gets Mega Project Status; ₹275 Cr Expansion with Govt Incentives Read Post »
Enviro Infra Engineers Bags ₹972 Cr Maharashtra STP Projects Under Swachh Bharat Mission 11/04/2026 / Order Wins & Contracts / EPC Infrastructure Contracts Enviro Infra Engineers Bags ₹972 Cr Maharashtra STP Projects Under Swachh Bharat Mission Read Post »
Panacea Biotec Wins ₹20.79 Cr Government Vaccine Supply Order 11/04/2026 / Order Wins & Contracts / Government Vaccine Supply Contract Panacea Biotec Wins ₹20.79 Cr Government Vaccine Supply Order Read Post »
Elitecon International Faces ₹221.89 Cr GST Show Cause Notice 11/04/2026 / Material Events / Regulatory / Tax Dispute Elitecon International Faces ₹221.89 Cr GST Show Cause Notice Read Post »
John Cockerill India Placed on Rating Watch with Developing Implications by CARE 11/04/2026 / Material Events / Credit Rating Action John Cockerill India Placed on Rating Watch with Developing Implications by CARE Read Post »
THDC India Declares COD of 250 MW Tehri PSP Unit; NTPC Group Capacity Rises 11/04/2026 / Operations & Projects / Capacity Addition / Project Commissioning THDC India Declares COD of 250 MW Tehri PSP Unit; NTPC Group Capacity Rises Read Post »
GIC Re Receives ₹350 Cr Income Tax Demand Notice for FY23-24 11/04/2026 / Material Events / Regulatory / Tax Dispute GIC Re Receives ₹350 Cr Income Tax Demand Notice for FY23-24 Read Post »
Shriram Finance Upgraded to IND AAA by India Ratings 10/04/2026 / Material Events / Credit Rating Action Shriram Finance Upgraded to IND AAA by India Ratings Read Post »
EPACK Durable Receives ₹37.5 Cr PLI Incentive Disbursement 10/04/2026 / Fundraising / Government Incentive / Financial Support EPACK Durable Receives ₹37.5 Cr PLI Incentive Disbursement Read Post »
Torrent Pharma Clears USFDA Inspection with Zero Observations at Oncology Facility 10/04/2026 / Material Events / Regulatory Compliance Update Torrent Pharma Clears USFDA Inspection with Zero Observations at Oncology Facility Read Post »
